NCT02541019View on ClinicalTrials.gov

Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for the Prophylaxis of Postoperative Nausea and Vomiting (PONV) in Women Over 60 Years Undergoing Laparoscopic Cholecystectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

January 1, 2017

Study Completion Date

July 1, 2017

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

Ondansetron

4 mg IV, one minute before the anesthesia induction and 4 mg IV three times a day during two days after the surgery.

DRUG

Palonosetron

75 mcg IV, one minute before the anesthesia induction.

Trial Locations (1)

21041-030

Hospital Federal de Bonsucesso, Rio de Janeiro

All Listed Sponsors
lead

Hospital Federal de Bonsucesso

OTHER

NCT02541019 - Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for the Prophylaxis of Postoperative Nausea and Vomiting (PONV) in Women Over 60 Years Undergoing Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter